Jennifer A. Fox
Director · Apogee Therapeutics, Inc.
Individual
- 2024
- Sep 3, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer A. Fox files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Michael Thomas Henderson - $26.88M in APGE purchases and sales in the last 12 months
- Carl Dambkowski - $8.50M in APGE purchases and sales in the last 12 months
- Jane Henderson - $1.36M in APGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer A. Fox?
Jennifer A. Fox is a corporate insider, tracked as Director of Apogee Therapeutics, Inc. (APGE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer A. Fox submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
